The development of vaccines is often more cautious due to their preventive nature, aimed at healthy populations, while antivirals can be expedited since they're used for those already ill. Urgency in therapeutic evaluation is heightened during health crises, leading to the repurposing of existing drugs. Ultimately, a comprehensive approach is essential, combining diagnostics, preventive measures, and effective treatments for future outbreaks.
